Single nucleotide polymorphisms in surfactant protein A1 are not associated with a lack of responsiveness to antenatal steroid therapy in a pregnant sheep model
Abstract Treatment with antenatal steroids (ANS) is standard practice for reducing the risk of respiratory distress in the preterm infant. Despite clear overall benefits when appropriately administered, many fetuses fail to derive benefit from ANS therapies. In standardized experiments using a pregn...
Main Authors: | Tsukasa Takahashi, Yuki Takahashi, Erin L. Fee, Haruo Usuda, Lucy Furfaro, John P. Newnham, Alan H. Jobe, Matthew W. Kemp |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.15477 |
Similar Items
-
Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
by: Carolina Bibbo, et al.
Published: (2019-04-01) -
Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial
by: Ayesha De Costa, et al.
Published: (2022-12-01) -
The role of antenatal corticosteroids in twin pregnancy
by: Jie Zhu, et al.
Published: (2023-02-01) -
The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
by: Suada Heljić, et al.
Published: (2009-08-01) -
Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
by: Fatma Mohamed, et al.
Published: (2021-04-01)